Doximity, Inc. (NASDAQ:DOCS) Shares Purchased by Bank of Montreal Can

Bank of Montreal Can increased its holdings in Doximity, Inc. (NASDAQ:DOCS) by 43.4% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 21,412 shares of the company’s stock after buying an additional 6,480 shares during the period. Bank of Montreal Can’s holdings in Doximity were worth $599,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. William Blair Investment Management LLC purchased a new position in shares of Doximity in the 1st quarter worth about $148,823,000. Swedbank AB bought a new position in Doximity in the 1st quarter worth approximately $91,673,000. Capital World Investors lifted its stake in shares of Doximity by 250.7% in the 1st quarter. Capital World Investors now owns 1,714,707 shares of the company’s stock worth $46,143,000 after acquiring an additional 1,225,707 shares during the period. Janus Henderson Group PLC lifted its holdings in Doximity by 33.5% in the 1st quarter. Janus Henderson Group PLC now owns 2,474,695 shares of the company’s stock valued at $66,594,000 after acquiring an additional 621,590 shares during the last quarter. Finally, Jacobs Levy Equity Management Inc. acquired a new position in shares of Doximity in the 1st quarter worth $8,541,000. Hedge funds and other institutional investors own 87.19% of the company’s stock.

Analysts Set New Price Targets

Several research firms have weighed in on DOCS. Morgan Stanley lifted their target price on Doximity from $25.00 to $26.00 and gave the company an “underweight” rating in a research note on Friday, August 9th. Needham & Company LLC upgraded shares of Doximity from a “hold” rating to a “buy” rating and set a $38.00 target price for the company in a research note on Friday, August 9th. JPMorgan Chase & Co. raised their target price on Doximity from $27.00 to $30.00 and gave the stock a “neutral” rating in a research report on Monday, August 19th. Barclays increased their price objective on shares of Doximity from $31.00 to $35.00 and gave the stock an “equal weight” rating in a report on Friday, August 9th. Finally, Wells Fargo & Company downgraded shares of Doximity from an “equal weight” rating to an “underweight” rating and dropped their price target for the stock from $27.00 to $19.00 in a research note on Thursday, July 18th. Two research analysts have rated the stock with a sell rating, eight have given a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $34.42.

Insider Activity

In related news, CFO Anna Bryson sold 30,000 shares of the firm’s stock in a transaction dated Friday, August 9th. The stock was sold at an average price of $35.00, for a total value of $1,050,000.00. Following the sale, the chief financial officer now directly owns 309,627 shares of the company’s stock, valued at $10,836,945. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. In other news, CFO Anna Bryson sold 30,000 shares of the business’s stock in a transaction dated Friday, August 9th. The stock was sold at an average price of $35.00, for a total transaction of $1,050,000.00. Following the sale, the chief financial officer now directly owns 309,627 shares in the company, valued at approximately $10,836,945. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Kira Scherer Wampler sold 2,500 shares of the business’s stock in a transaction on Thursday, August 1st. The stock was sold at an average price of $28.18, for a total transaction of $70,450.00. Following the completion of the sale, the director now directly owns 10,258 shares in the company, valued at approximately $289,070.44. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 35,451 shares of company stock worth $1,201,018. 39.40% of the stock is currently owned by company insiders.

Doximity Trading Up 2.5 %

Shares of DOCS stock opened at $44.32 on Wednesday. Doximity, Inc. has a 1 year low of $19.89 and a 1 year high of $44.88. The firm has a market capitalization of $8.22 billion, a P/E ratio of 61.56, a PEG ratio of 5.80 and a beta of 1.29. The firm’s fifty day moving average price is $36.65 and its two-hundred day moving average price is $30.24.

Doximity (NASDAQ:DOCS) last posted its quarterly earnings results on Thursday, August 8th. The company reported $0.22 earnings per share for the quarter, beating analysts’ consensus estimates of $0.16 by $0.06. The business had revenue of $126.68 million for the quarter, compared to analysts’ expectations of $119.88 million. Doximity had a return on equity of 19.26% and a net margin of 32.53%. As a group, equities research analysts forecast that Doximity, Inc. will post 0.8 EPS for the current fiscal year.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.